StockNews.com assumed coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a report published on Thursday morning. The firm issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 price objective on shares of Kamada in a report on Thursday, May 9th. Check Out […]